Evolent Health Inc (EVH)
26.96
-0.31
(-1.14%)
USD |
NYSE |
May 09, 16:00
28.40
+1.44
(+5.34%)
Pre-Market: 20:00
Evolent Health Total Liabilities (Quarterly): 1.613B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.613B |
| September 30, 2023 | 1.574B |
| June 30, 2023 | 1.554B |
| March 31, 2023 | 1.297B |
| December 31, 2022 | 957.88M |
| September 30, 2022 | 903.04M |
| June 30, 2022 | 690.82M |
| March 31, 2022 | 727.94M |
| December 31, 2021 | 725.82M |
| September 30, 2021 | 646.04M |
| June 30, 2021 | 679.18M |
| March 31, 2021 | 688.29M |
| December 31, 2020 | 752.10M |
| September 30, 2020 | 737.04M |
| June 30, 2020 | 623.27M |
| March 31, 2020 | 603.68M |
| December 31, 2019 | 568.97M |
| September 30, 2019 | 589.55M |
| June 30, 2019 | 505.50M |
| Date | Value |
|---|---|
| March 31, 2019 | 479.25M |
| December 31, 2018 | 532.92M |
| September 30, 2018 | 274.10M |
| June 30, 2018 | 270.24M |
| March 31, 2018 | 251.40M |
| December 31, 2017 | 266.39M |
| September 30, 2017 | 243.25M |
| June 30, 2017 | 243.90M |
| March 31, 2017 | 257.71M |
| December 31, 2016 | 287.72M |
| September 30, 2016 | 91.42M |
| June 30, 2016 | 84.66M |
| March 31, 2016 | 80.80M |
| December 31, 2015 | 80.94M |
| September 30, 2015 | 120.13M |
| June 30, 2015 | 91.13M |
| March 31, 2015 | 68.72M |
| December 31, 2014 | 39.27M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
505.50M
Minimum
Jun 2019
1.613B
Maximum
Dec 2023
865.05M
Average
725.82M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| American Shared Hospital Services | 21.88M |
| Novo Integrated Sciences Inc | 13.06M |
| Astrana Health Inc | 773.86M |
| Cryo-Cell International Inc | 72.05M |
| P3 Health Partners Inc | 427.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.680B |
| Shareholders Equity (Quarterly) | 1.068B |
| Debt to Equity Ratio | 0.5592 |
| Current Ratio | 1.014 |
| Net Debt Paydown Yield | -0.98% |